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Abstract 
Isotope tracer studies, particularly radiocarbon measurements, play a key role in biological, 
nutritional, and environmental research. Accelerator mass spectrometry (AMS) is now the most 
sensitive detection method for radiocarbon, but AMS is not widely used in kinetic studies of 
humans. Part of the reason is the expense, but costs would decrease if AMS were used more 
widely. One component in the cost is sample preparation for AMS. Biological and environmental 
samples are commonly reduced to graphite before they are analyzed by AMS. Improvements and 
mechanization of this multi-step procedure is slowed by a lack of organized educational materials 
for AMS sample preparation that would allow new investigators to work with the technique 
without a substantial outlay of time and effort. We present a detailed sample preparation protocol 
for graphitizing biological samples for AMS and include examples of nutrition studies that have 
used this procedure. 
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graphitization  
 Introduction 
Accelerator mass spectrometry (AMS) is the most sensitive radioisotope detection method and 
has the lowest quantification limits of currently available measurement techniques. It is a 
fundamental tool in archeology, oceanography and geosciences due to this high sensitivity 
(Kutschera, 2005). It is suitable for the biological sciences because AMS studies can use doses of 
radioisotopes which cause minimal radiation exposures that are below safety thresholds, so that 
they can be used in a greater variety of human studies. There are also less waste disposal problems 
than traditional radioisotope methods. Furthermore, the low dose and specific activity can greatly 
reduce costs. 
 
Although 90% of all AMS measurements worldwide are devoted to radiocarbon, its value for 
applications in biological and clinical studies is less well appreciated. Isotope labels provide 
chemically exact analogues of almost any compound, so AMS is suitable for studies of the 
absorption, distribution, metabolism, and excretion of pharmaceutical compounds. Radioactive 
drug candidates can trace metabolic intermediates, macromolecular adducts, or receptor/ligand 
interactions. In nutrition studies, tracer methods enable scientists to determine the fate of a labeled 
nutrient from digestion and absorption through metabolism and excretion directly in human 
subjects. Since AMS is an isotope ratio measurement, the results provide a tissue concentration for 
the traced compound, greatly simplifying experimental protocols. 
 
Despite these advantages, AMS is rarely used in nutritional studies. A major reason for the slow 
adoption by the biological sciences is that AMS sample preparation is still a complex laboratory 
procedure. Biological samples are usually converted to graphite before they are analyzed. This is a 
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2-step process. The first step oxidizes solid or liquid tissue carbon to CO2 gas. The second step 
reduces the CO2 gas to graphite that is analyzed for 14C by AMS. Clear, detailed protocols 
describing AMS sample preparation for investigators new to AMS would help its use. The 
objective of this paper is to present a detailed sample preparation procedure for converting 
biological carbon (urine, feces, tissue, and blood samples) to graphite for AMS. 
Materials and Methods 
Materials 
An itemized list of equipment, chemicals, and other supplies used by our group for graphite 
preparation is given in Table 1. Materials can be obtained from suppliers other than those listed in 
Table 1. Plans for the construction of “Custom made” items are available from the corresponding 
author. Special AMS sample holders for graphitized samples are ion-source-specific and are 
provided by the AMS laboratory.  
Material-Cleaning Procedures 
The 6 mm quartz sample tubes (4 mm ID x 6 mm OD  x 38 mm L) for biological samples and the 9 
mm break-end quartz combustion tubes (7 mm ID x 9 mm OD x 18 cm L) are heated at 900oC in air 
for 2.5 h prior to use to remove organic contaminants.  The 6 mm borosilicate glass (Pyrex®, Kimax, 
or other generic borosilicate glass) sample tubes (6 mm OD x 50 mm L) for HPLC fractions are 
heated in air at 500oC for 2 hr to remove organic contaminants.  Copper (II) oxide (CuO) reagent 
wire (Sigma-Aldrich 31,043-3) is also heated in air at 500oC for 2 hr to remove organic 
contaminants including adsorbed copper carbonate.   
The iron powder (Sigma-Aldrich 25,563-7) must be kept well sealed between usages to minimize 
atmospheric contamination.  The same is true for the zinc dust (Sigma-Aldrich 20,998-8).  
Sample Collection  
All sample collection and preparation should adhere to procedures that are known to minimize 
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contaminations of samples from inadvertent movement of normally undetectable isotope 
concentrations in the laboratory (Buchholz, et al., 2000). For human in vivo studies, the subject is 
orally or intravenously administered a small tracer dose (1-100 nCi) of 14C-labeled micronutrient, 
food component, or pharmaceutical. Tissues (such as blood, feces, urine, saliva, skin, needle 
biopsies, or breath) are sampled as a function of time since dosing, then stored at -80oC in glass or 
suitable plastic vials and bottles until preparation for analysis. Refrigeration to -20°C is acceptable 
if the samples will be stored for only a few days and if all of the traced compounds and metabolites 
are stable and non-volatile. Indwelling catheters are used for collecting frequent small blood 
samples that reflect absorption kinetics shortly after dosing. 
Sample drying 
After thawing a stored biological sample (or directly after collecting a fresh sample), small aliquots 
(20 µl plasma, 100 µl urine, 5 mg wet tissue, 75 µl homogenized feces, etc) containing 0.5 - 2 mg of 
carbon (Vogel & Love, 2005) are first placed into a 6 mm quartz sample tube (Table 1).  HPLC 
fractions are automatically collected into 6 mm borosilicate tubes. The 6 mm quartz or borosilicate 
sample tube is then nested inside a second 10 mm borosilicate glass culture tube (Pyrex®, Kimax, 
or other generic borosilicate glass, 10 mm OD x 75 mm L) that is further nested inside a third 13 
mm borosilicate glass culture tube (Pyrex®, Kimax, or other generic borosilicate glass, 13 mm OD x 
100 mm L) that is nested inside a fourth 15 ml Falcon tube, which fits into a centrifugal evaporator 
(Figure 1A).  The biological samples are then evaporated to dryness and the Falcon tube is capped 
promptly and stored.  
This nesting is necessary for lack of a suitable rotor for our evaporator and some nesting facilitates 
handling and avoids touching and contaminating the exterior of the 6 mm quartz or borosilicate 
sample tube.  Careful maintenance of the vacuum system minimizes the time needed to dry the 
samples and this in turn can minimize inter-sample contamination with aerosols from the vacuum.  
Transfer of samples to combustion tubes 
After each biological sample is evaporated to dryness only the 6 mm quartz or borosilicate sample 
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tube is carefully removed using a single surface-use disposable wipe, a small amount of copper (II) 
oxide reagent wire (~ 40 mg) is added, and all nesting tubes are discarded.  Nitrogen-rich biological 
samples, such as urine, may require a small amount of added elemental copper reagent (10-20 mg) 
(Sigma-Aldrich 31,140-5) to insure that nitrogen oxides produced in combustion are reduced to N2.  
The 6 mm quartz or borosilicate sample tube is placed in the 9 mm break-end quartz combustion 
tube (Table 1). The 9 mm break-end quartz combustion tube, loaded with the 6 mm quartz or 
borosilicate sample tube containing copper (II) oxide reagent wire (and elemental copper as needed 
for nitrogen rich biological samples), is gently pushed into one of the o-ring-sealed ports (Swagelok 
Ultra-Torr, Solon, OH, USA) of the stainless steel vacuum manifold (Figure 1B). The vacuum 
valve is slowly opened, the break-end quartz combustion tube is evacuated to < 10 mTorr and then 
flame-sealed with a hydrogen or oxyacetylene torch.  
Combustion 
The flame-sealed 9 mm quartz combustion tubes are placed in a metal magazine containing 20 slots 
total (Figure 1B) and baked at 900oC when using quartz sample tubes, and 650ºC when using 
borosilicate sample tubes for 2.5 hr followed by a slow cooling back to room temperature within 
the oven.  The magazine keeps the tubes in an ordered array and prevents destruction of multiple 
samples if one tube blows up due to an excess of sample material. The combustion reaction is 
shown below. 
Eq. 1: Dried biological sample + CuO !!!! "! hrC
o
5.2900  Cu2O/Cu + CO2 + H2O + N2 + SO2 +... 
The adequacy of copper (II) oxide added to the 6 mm quartz or borosilicate sample tube can be 
checked by the presence of copper (II) oxide in the 6 mm quartz or borosilicate sample tube after 
combustion.  Incomplete combustion is indicated when there is a complete lack of copper (II) 
oxide (black appearance) in the combusted sample.  
During combustion, any volatile sodium that is generated migrates into the glass of the 9 mm 
break-end quartz combustion tube and will weaken or even decompose the quartz. Therefore, 
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potassium buffer salts are used whenever possible in performing AMS experiments.  
Samples with intrinsically high salt content, such as urine, may be combusted at lower 
temperatures (500-650oC) to reduce this destructive sodium migration into the 9 mm quartz 
combustion tube. These samples may also be aliquotted in 6 mm borosilicate glass sample tubes 
rather than the 6 mm quartz sample tubes when lower combustion temperatures are being used.  
Combusted samples may be stored for a few days before significant deterioration of CO2 to form 
copper carbonate occurs.  If the combustion tubes are stored for longer periods, they need to be 
re-heated to 500°C for one hour. 
Samples containing 0.5 - 2 mg of carbon are ideal for making good graphite (Buchholz et al 1999 b, 
Vogel & Love, 2005).  However, this amount of sample is not always available in the isolated 
fraction, and tributyrin (glycerol tributanoate) is used as a source of supplemental carbon (carbon 
carrier) for carbon-poor samples (< 10 µg) due to its relatively low 14C, high carbon, low nitrogen, 
low vapor pressure, high solubility in alcohol, low toxicity, and good retention of volatile 
components (Buchholz et al 1999 b). However, tributyrin from different sources can differ in 14C 
content (Table 2).  Tributyrin with low 14C is used to maintain a significant signal to background 
level, but the finite 14C content provides an alert of unexpected 14C-depleted carbon in the collected 
sample (Vogel & Love, 2005), which is not available from 14C-free carrier.  The difference in 
tributyrin 14C levels between combustion in 6 mm quartz at 900°C for 2.5 hr (0.111 ± 0.025 Mod) 
and 6 mm borosilicate glass at 650oC for 2 hr (0.118 ± 0.024 Mod) is not significant. 
Preparing septa-sealed vials 
The septa-sealed vial and gas transfer setup is shown in Figure 2 and is based on the procedures 
described by Ognibene, et al., 2003.  It consists of a septa-sealed vial (Pyrex®, Kimax, or other 
generic borosilicate glass, 8 mm OD x 80 mm L) and an inner vial (Pyrex®, Kimax, or other generic 
borosilicate glass, 3.7 mm OD x 30 mm L) as described in Table 1. Three scoops (~100. mg) of 
zinc dust are added to the septa-sealed vial using a 3.5 mm curette (Miltex Instruments, Chalazion 
Curette #18-506, Bangor ME, USA) followed by four glass beads (3 mm) that are dropped atop 
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the zinc dust.   About 10 mg of spherical iron powder is added to the inner vial that is then placed 
atop the glass beads.  The glass beads keep the inner vial separated from the zinc dust.  The 
septa-sealed vial is then crimp-sealed.  Large numbers of the septa-sealed vials may be assembled 
and stored upright for several weeks prior to use.  
Gas transfer  
After the biological sample is combusted to CO2 gas, the gas must be transferred to the 
septa-sealed vial. This is done by connecting the break-end quartz combustion tube to a gas 
transferring apparatus (Figure 2). The apparatus consists of the break-end quartz combustion 
tube connected to 7.2 cm long Nalgene tubing (5/16" ID x 1/2" OD) which is connected to a 
disposable 4-way stopcock via a male Luer.  Next, the loaded septa-sealed vial is inserted into the 
base of the needle port. Once inserted the loaded septa-sealed vial is connected to a second arm of 
the 4-way stopcock by a 26 gauge, 3/8 inch long needle (26G⅜”). The third arm of the stopcock is 
connected to a vacuum pump with a vacuum gauge controller (Table 1, Figure 2).  
The Nalgene tube connecting the break-end quartz combustion tube to the male Luer is evacuated 
first to < 3 mTorr.  The septa-sealed vial is then evacuated to < 3 mTorr.  A Dewar flask containing 
liquid nitrogen is placed below the septa-sealed vial and raised just above the level of zinc dust 
using a laboratory jack. The top port of the 4-way stopcock is closed to the vacuum pump and 
opened to connect the 9 mm quartz combustion tube to the septa-sealed vial.   The break seal is 
snapped to allow transfer of CO2 from the 9 mm quartz combustion tube to the septa-sealed vial.  
The CO2 gas is cryogenically trapped in the septa-sealed vial, two white bands of frozen 
condensable products (mostly CO2 and H2O) will appear at the top of the liquid nitrogen contact. 
The combustion products of samples that produce large amounts of nitrogen or other 
non-condensable gasses must be carefully handled, since the uncondensible gasses warm the inner 
surface of the condensate to a temperature at which the CO2 no longer solidifies.  A new 
condensing surface is created by raising the liquid nitrogen level by a few mm, which usually 
produces another condensation ring. When transferring nitrogen-rich biological samples, e.g. urine 
or protein extractions, this process of raising the liquid nitrogen level a few mm at a time is 
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repeated until space precludes it or until no new condensation rings appear. Non-condensable 
products in the septa-sealed vial are then removed by reopening the top port of the 4-way 
stopcock to the vacuum pump. The entire transfer process takes 1 min for simple samples. After 
gas transfer is complete, the septa-sealed vial is removed from the needle port of the 4-way 
stopcock and labeled, and its CO2 is ready for reduction to graphite. 
Reducing CO2 to graphite 
The septa-sealed vial containing CO2 is placed in a heating block at 525oC for 6 hr (Figure 2).  The 
reaction is only mildly sensitive to temperature, with quantitative yields occurring at 450-650oC 
(Vogel, et al. 1984, 1987; Vogel, 1992; McNichol, et al., 1992). The reaction temperature is not 
critical, but it must be well controlled at or below the glass softening temperature.  The 
septa-sealed vials (melting point: 820°C) will soften within the heater holes at temperatures above 
650°C and can be difficult to remove from the heating block. The septa-sealed vial may be left in 
the slowly cooling heater block if a timer is set to turn off the heater for ease of “overnight” 
reductions. The CO2 is reduced to graphite that coats the iron catalyst within the septa-sealed 
inner vial.  The chemical reactions that occur during reduction of CO2 to graphite are shown below.  
Eq. 2a   CO2 + Zn !"  CO + ZnO 
Eq. 2b   H2O + Zn !"  H2 + ZnO  
Eq. 2c   CO + H2 !!! "! CatalystFe  Graphite + H2O 
Water produced from the combustion process is reduced to form the hydrogen required to drive 
the graphite production. Therefore, the CO2 produced in the combustion is not “dried” to remove 
water vapor. Sulfur compounds are quickly reduced to zinc sulfide, removing an important 
“poison” of the iron catalytic reaction. Any non-condensable nitrogen remaining in the 
septa-sealed vial is inert to these reactants. The resultant graphite is highly absorptive of volatile 
organic vapors (Buchholz, et al., 2000), and the cooled, septa-sealed vials are the best storage 
option for the prepared graphite sample until it is pressed/tamped/hammered/packed into the 
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AMS sample holder. 
Loading graphite into the AMS sample holders  
AMS sample holders and the procedures used to load them are AMS-instrument-specific. The 
procedure for loading graphitized samples into AMS sample holder for the Lawrence Livermore 
National Laboratory (LLNL) is shown in Figure 3. The graphite-coated iron is removed from the 
septa-sealed vial by “decapping” the septa seal.  The graphite-coated iron is poured into a conical 
depression that surrounds the 2.5 mm-deep, 1.32 mm diameter hole drilled into the 9.5 x 29 mm 
cylindrical aluminum sample holder provided by LLNL’s AMS group.  A mini-Plexiglas hood (2 x 
1 ft) connected to a low vacuum is used to reduce powder dispersion and prevent sample 
contamination while loading the graphite into the AMS sample holder. The graphite sample is 
pressed/tamped/hammered/packed into the hole with a new #55 gauge drill blank cleaned with 
emery paper (Table 1, Figure 3).  The final graphite surface should be ≥ 1 mm from the top of the 
hole.  It is not always possible to transfer all of the graphitized sample into the AMS sample 
holder.  The LLNL ion source performance is independent of the packing pressure, but sufficient 
pressing/tamping/hammering/packing is important for the sample to stay in the AMS sample 
holder during shipping and handling. The AMS sample holders are then packed and shipped to 
LLNL for measuring 14C using AMS. The 14C/13C ratios measured experimentally are normalized 
to measurements of standards of known 14C concentration (e.g. Australian National University 
sucrose, ANU) (Vogel & Love, 2005).  
 
 
Results 
We used these AMS procedures to increase fundamental knowledge of the basic biochemistries of 
folate and carotenoid metabolism. Sample datasets from these studies are shown in Figures 4 to 6. 
Folate functions as a cofactor in the transfer and utilization of 1-carbon groups. AMS was used to 
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study the metabolism of small tracer oral doses of 14C pteroylmonoglutamate (a form of folate) in 
plasma, and erythrocytes (RBC) from blood drawn over a 202-day period and in urine and feces 
collected over a 44-day period from a healthy human volunteer (Buchholz, et al. 1999a). This 
study indicated that 90% of the dose was absorbed and more than 75% was retained in the body 
after 42 days.  In another study, AMS was used to assess the kinetics of folate metabolism from 
oral dose of [14C]pteroylmonoglutamate in 13 human volunteers (Lin, et al., 2004). Figure 4 
shows the trace of folate in the erythrocytes, and Figure 5 shows the elimination of the 14C tracer 
in the urine and feces. Figures 4 to 6 show some characteristic difficulties and advantages 
associated with nutritional and biological samples. Specifically, the scientist must work with a 
large series of similar, relatively homogenous samples to obtain useful data, but the samples are 
good candidates for batch processing, automation, and potentially, direct injection of combustion 
CO2 into a gas-accepting ion source (Liberman, et al. 2004). The results from these studies were 
used to construct a kinetic model of folate metabolism, which indicated that the absorbed fraction 
of the administered dose ranged from 65 to 97% with mean value of 79 %, and there was no 
correlation between fractional absorption and intake of folate. Understanding the extent of 
bioavailability of folate that can be achieved by radioisotope measurement using AMS is key to 
establishing intake levels for optimal health.  
We conducted similar studies with ß-carotene, one of a large group of pigments known as 
carotenoids, some of which serve as metabolic precursors to vitamin A. The benefits of ß-carotene 
to health may extend well beyond its function as a vitamin A source, although there have been 
contradictory reports on the health benefits of ß-carotene. The nutritional and chemo-preventive 
role played by ß-carotene is not well understood due to the complexity in its absorption, transport 
across tissues, and its subsequent metabolism. We administered 14C-labeled ß-carotene to an adult 
human subject and determined its half-life in blood, its bioavailability, and bioconversion to 
vitamin A (Dueker, et al., 2000). Figure 6 shows the parent compound and its metabolites in 
plasma by time since dose; the ability to trace the 14C parent and 14C metabolites (even if chemical 
identity is unknown) is a major advantage of AMS. We determined that about 43% of the dosed 
ß-carotene was absorbed in the first 48-hr collection period and that 1 mol ß-carotene converted to 
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0.6 mol vitamin A. After vitamin A supplementation, higher absorption resulted in larger molar 
vitamin A values (Lemke, et al., 2003). 
 
Discussion 
Quantifying the 14C content of biological samples is a 2-step process. Step 1 is to convert sample 
carbon to a form compatible with the AMS ion source, graphite for most AMS spectrometers; and 
step 2 is to obtain the isotope ratio of that prepared material normalized to similarly prepared 
known isotopic standards using AMS. These steps are operationally easily separated, so a remote 
AMS can easily serve scattered research groups that correctly reduce their samples to the 
particular form required for AMS measurement.  
AMS has been specifically designed to measure 14C with the exclusion of potential molecular and 
isobaric interferences through energetic collisions followed by momentum and mass spectrometries. 
The final ion detector can identify charge and mass of the incident ions to further resolve specific 
isotopic ions. The complete discrimination against 14N (the nuclear isobar of 14C) through negative 
ionization (Buckman & Clark, 1994) reduces the task of the spectrometer to that of complete 
destruction and ion separation of molecular isobars, primarily 12CH2  and 13CH, allowing for the 
development of the spectrometers that operate at lower acceleration energies (200-500 kV). The 
high selectivity of AMS spectrometers thus dictates that the sample preparation deliver 
quantitative, uncontaminated, consistent samples that produce high ion outputs, usually 
graphite-coated on an iron catalyst/binder powder. The procedures listed here have produced 
many thousands of samples for the study of human metabolism and transport of essential, 
low-dose vitamins.   
 
 
Conclusion 
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AMS is an exceptionally powerful tool for metabolic research, but the growth of AMS as a 
research tool has been limited because AMS sample preparation methods require attention to 
details that prevent contamination in a tracing laboratory. There is a dearth of educational 
opportunities and training tools for teaching AMS methods to new investigators. We provide 
detailed descriptions and diagrams of our sample preparation procedures for converting fecal, urine, 
blood or other biological samples to graphite for AMS. Further advances in AMS sample 
preparation methods and more collaboration between end-users and AMS providers are needed 
and should result in more widespread and more cost-effective usage of this powerful technique. 
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Table 1. Equipment, chemicals, and other supplies used in graphite preparation. 
Item Description Supplier Catalog # 
Sample processing    
Jouan RC 10.10 Vacuum Concentrator Jouan Inc., Winchester VA, USA  
Unijet II Refrigerated Aspirator Uniequip, Munich, Germany  
Borosilicate glass (Pyrex®, Kimax, or other generic 
borosilicate glass, 6mm OD x 50 mm L) 
Kimble Glass Inc. Vine land, NJ USA 45060-650 
Borosilicate glass culture tube (Pyrex®, Kimax, or 
other generic borosilicate glass, 10mm OD x 75 
mm L) 
Fisher Scientific Inc. Allentown, PA, USA 16-961-25 
Borosilicate glass culture tube (Pyrex®, Kimax, or 
other generic borosilicate glass,  13 mm OD x 100 
mm L) 
Fisher Scientific Inc. Allentown, PA, USA 16-961-27 
Quartz sample tube  
(4 mm ID x 6 mm OD x 38mm L, CFQ) 
Custom made of quartz tubing from GM Associates, 
Oakland, CA, USA or tubes from Mel Hart Assoc, 
Longwood, FL, USA 
Tubing # 
6000-8 
Falcon tube (15 ml) Becton Dickinson Labware, Franklin Lakes, NJ  
Porcelain evaporating dish VWR International, Brisbane, CA, USA 25310-256 
Tributyrin MP Biomedical, Solon, OH, USA 103111 
ANU sugar standards Australia National University  
   
Combustion   
Break-end Quartz combustion tube (7mm ID x 9 
mm OD x 18cm L, CFQ) 
Custom made of quartz tubing from GM Associates, 
Oakland, CA, USA or tubes from Mel Hart Assoc, 
Longwood, FL, USA 
Tubing # 
6000-14 
Vacuum pump (turbo-V70) Varian, Palo Alto, CA, USA  
316 Vacuum gauge controller Granville-Phillips, Longmont, CO, USA  
Convectron gauge (pressure sensor) Helix Technology, Longmont, CO, USA 275071 
Copper reagent, granular, 99.90+ % Sigma-Aldrich, St. Louis, MO, USA 31,140-5 
Copper (II) oxide reagent, mixture of CuO and 
Cu2O, wire 
Sigma-Aldrich, St. Louis, MO, USA 31,043-3 
Vulcan Box Furnace with programmable controls DENTSPLY, Burlington, NJ, USA  
Magazine Custom made, plans available from corresponding author  
   
Gas transfer   
Iron powder, 99.99+% Sigma-Aldrich, St. Louis, MO, USA 25,563-7 
Zinc, Dust, < 10 micron, 98+% Sigma-Aldrich, St. Louis, MO, USA 20,998-8 
Laboratory Jack Fisher Scientific Inc. Allentown, PA, USA 14-673-50 
Dewar shielded vacuum flask VWR International, Brisbane, CA, USA 63422-028 
Septa-sealed vials  (Pyrex®, Kimax, or other 
generic borosilicate glass,  8.0 mm OD x 80 mm L)  
Kimax, Custom made by Kimble Kontes Scientific 
Glassware, Vineland, NJ, USA 
 
Septa-sealed inner vials (Pyrex®, Kimax, or other 
generic borosilicate glass, 3.0 mm ID x 3.7 mm 
Pyrex®, Scientific Instruments Service, Inc. Ringoes, NJ. 
USA 
GSV500 
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OD x 30 mm L)  
Pyrex® beads (Pyrex®, Kimax, or other generic 
borosilicate glass, 3 mm diameter) 
VWR, Brisbane, CA USA 26396-803 
8 mm crimp seal, TEF/SIL Fisher Scientific Inc. Allentown, PA, USA 69008-4A 
Nalgene tubing (5/16" ID x 1/2" OD) VWR, Brisbane, CA USA 632013-506 
BD single use 26 G ⅜" needles Fisher Scientific Inc. Allentown, PA, USA 14-826-10 
Stopcocks (4-way stopcocks) Qosina, Edgewood, NY, USA 99701 
Male Luers  Qosina, Edgewood, NY, USA 64014 
   
Reducing CO2 to graphite   
Heating block with 60 tube capacity Custom made, plans available from corresponding author  
   
Loading graphite into the AMS sample holder    
Plexiglas box Custom made, plans available from corresponding author  
#55 gauge drill blanks (Morse, Vermont Drill, or 
any other manufacturer) 
Morse Cutting Tools, Madison Heights, MI USA  
Vermont American, Mount Prospect, IL USA 
 1439 
AMS sample holders LLNL, Livermore, CA  
Anvil Custom made, plans available from corresponding author  
Vacuum (Wet/Dry Vac) Shop-Vac Corporation Williamsport, PA, USA Model2010 
Hammer 3 kg weight   
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Table 2. Comparison of tributyrins and benzoic acid for 14C content measured by AMS. 
 
Carbon  sources n 14C (Fraction Modern) 
  Mean Std. error 
Tributyrin, MP1 10 0.018d 0.001 
Tributyrin, LLNL2 10 0.100b 0.002 
Tributyrin, Fluka3 9 0.239a 0.002 
Benzoic acid4 (2 mg) 5 0.028c 0.002 
Benzoic acid (2 µl) 5 0.024c 0.002 
 
1MP Biomedicals, Solon, OH (#103111) 
2Tributryin obtained from LLNL (ICN Pharmaceuticals, Costa Mesa, CA) 
3Fluka, Chemical Corp. St. Louis, MO (#91010) 
4Fluka, Chemical Corp. St. Louis, MO (#12353) 
a-d Means with different superscript are significantly different from one and another (P < 0.001). 
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Figure Legends 
Figures 1 through 3 shows the steps used to convert biological carbon to graphitized CO2.  
Figure 1. Converting sample carbon to CO2.  
Figure 2. Transferring CO2 gas to septa-sealed vial and reduction to graphite. 
Figure 3. Loading AMS sample holder with graphite-coated iron. 
Figure 4. Ratio of 14C to total carbon in plasma and erythrocytes of an adult human by time since 
administration of a very small oral dose of 14C-folic acid.  
Figure 5. Ratio of 14C to total carbon in urine and feces of an adult human by time since 
administration of a very small oral dose of 14C-folic acid.  
Figure 6. Fraction of an administration of a dose of 14C-β-carotene that appears in plasma 14C 
-retinyl ester, 14C-retinol, and 14C-β-carotene as a function of time since dosing. 
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Figure 1. Converting sample carbon to CO2.  
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borosilicate 
tube  
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tube 
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Load quartz 
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tube 
  
Vacuum, 
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with torch  
2 
Flame 
To 
vacuum 
pump 
≈ 2 cm 
7mm x 9mm x18cm  
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combustion tube 
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vacuum. 
 
2) Heat & seal 
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quartz  
combustion 
tube 
In 
line 
filter 
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Figure 2. Transferring CO2 gas to septa-sealed vial and reduction to graphite. 
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Figure 3. Loading AMS sample holder with graphite-coated iron. 
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Figure 4. Ratio of 14C to total carbon in plasma and erythrocytes of an adult human by time since 
administration of a very small oral dose of 14C-folic acid. 
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Figure 5. Ratio of 14C to total carbon in urine and feces of an adult human by time since 
administration of a very small oral dose of 14C-folic acid.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Fraction of an administration of a dose of 14C-β-carotene that appears in plasma 14C 
-retinyl ester, 14C-retinol, and 14C-β-carotene as a function of time since dosing.  
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